Twins resulting from subfertility treatment are born about 4 days sooner (95% CI; 2.7?5.2) and are about 60% more likely (OR 1.6; 1.4?1.8) to be born slightly preterm (between 34 and 36 weeks) when compared with naturally conceived twins, according to the results of a population-based cohort study from Belgium. But the differences are largely explained by a first birth effect among subfertile couples and are mitigated by the protective effect of dizygotic twinning; most twins resulting from subfertility treatment are dizygotic.
Twins resulting from subfertility treatment are born about 4 days sooner (95% CI; 2.7–5.2) and are about 60% more likely (OR 1.6; 1.4–1.8) to be born slightly preterm (between 34 and 36 weeks) when compared with naturally conceived twins, according to the results of a population-based cohort study from Belgium. But the differences are largely explained by a first birth effect among subfertile couples and are mitigated by the protective effect of dizygotic twinning; most twins resulting from subfertility treatment are dizygotic.
To obtain the findings, researchers looked at 2,915 spontaneous twins, 710 twins born after ovarian stimulation, and 743 twins born after in vitro fertilization or intracytoplasmic sperm injection.
While the study lacked data on potential confounding by socioeconomic status, it is the first population-based twin study to look at the relationship between subfertility treatment (rather than reproductive technologies) and gestational length.
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More